The Challenges

Bridging the Gap

Addressing the Disparity in Genomic Medicine in the Arab World

While genomic medicine is transforming health, the Arab world is lagging behind

Massive Under-Representation

Arabs account for 5% of the world population but 0.16% of genomic study participants

Rising Disease Burden

Highest rates of cardiometabolic disease globally

Missed Discovery Opportunities

Low contribution to drug discovery

Understanding the Unique Challenges

Adapting Genomic Medicine for the Arab WorldWorld

Genomic medicine holds great promise, but directly applying Western models to the Arab world presents several challenges. The following factors highlight why a tailored approach is essential for effective implementation:

Understanding the Impact and Necessity of Effective Solutions

The Problem

The rising prevalence of cardiometabolic diseases and cancer in the MENA region poses a significant challenge to public health systems and places a considerable strain on healthcare expenditure.

Burden of Cardiometabolic Diseases in the MENA Region

Poses a significant challenge to public health and places considerable strain on the region's healthcare expenditures.

Public Health Initiatives

Public health initiatives, awareness campaigns, and funds allocated for preventive measures and early intervention are crucial.

Prevalence of Cardiometabolic and Cancer Diseases

The increase in the prevalence of cardiovascular diseases and cancer not only leads to an elevated morbidity and mortality rate but also requires substantial financial investment.

Integrating Western Innovation with Local Expertis

A Tailored Genomic Medicine Solution for the Arab World

To effectively address the challenges of common diseases in the MENA region, a genomic medicine company must combine the best of Western advancements with a deep understanding of local needs. This approach ensures that genomic medicine is both cutting-edge and culturally relevant.
Informed by the West
Rooted in the Arab world

Perspective